- Home
- KYN vs CLDX Comparison
KYN vs CLDX Comparison
Compare KYN & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KYN | CLDX |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | KYN | CLDX |
|---|---|---|
| Price | $14.16 | $38.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $46.60 |
| AVG Volume (30 Days) | 370.3K | ★ 1.3M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 8.99% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | N/A | $111.39 |
| Revenue Next Year | N/A | $235.85 |
| P/E Ratio | $19.92 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $11.31 | $19.72 |
| 52 Week High | $14.70 | $40.30 |
Technical Indicators
Market Signals| Indicator | KYN | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 56.81 | 69.27 |
| Support Level | $13.62 | $28.51 |
| Resistance Level | $14.35 | N/A |
| Average True Range (ATR) | 0.25 | 1.70 |
| MACD | 0.07 | 0.41 |
| Stochastic Oscillator | 85.20 | 82.71 |
Price Performance
Historical ComparisonAbout KYN Kayne Anderson Energy Infrastructure Fund Inc.
Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.